Feasibility and Effectiveness of an Additional Resistance and Balance Training in Cardiac Rehabilitation of Older Patients After Valve Surgery or Intervention

July 14, 2020 updated by: Eglė Tamulevičiūtė-Prascienė, Lithuanian University of Health Sciences
The aim of the study is to evaluate the short- and medium-term effectiveness of additional moderate dynamic resistance and balance training to the CR-program of old adults after valve surgery or intervention compared to usual care-CR.

Study Overview

Study Type

Interventional

Enrollment (Actual)

116

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kulautuva
      • Kaunas, Kulautuva, Lithuania
        • LUHS hospital Kaunas Clinics Rehabilitation hospital of Kulautuva

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients after valve surgery and/or intervention
  • Age 65 years and older
  • Ability to start CR within 4 weeks after surgery,
  • 6-minute walk distance (6-MWD) ≥100- ≤350 m (1)
  • Patient's agreement to participate in the study.

Exclusion Criteria:

  • Diseases in the musculoskeletal system or other organs complicating physical activity and exercise training;
  • Exercise-limiting comorbidities (primarily orthopedic and neurological conditions that would exclude individuals from participating in CR according to study protocol), including chronic heart failure New York Heart Association Class IV, hemoglobin less than 9 g/dL, wound healing disturbance, cognitive or linguistic deficits.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
NO_INTERVENTION: Control group
The supervised exercise program included: continues endurance training on cycle ergometers (6 sessions a week). Every session included warm up (<50% target intensity 2 min, gradually increasing load 1-10 w/min up to target intensity within 5 - 10 min); exercise phase (100% of the target intensity (30-50% watts or 30-50% HRmax), starting with >5 minutes and gradually prolonged up to 30 min); cool down with gradual reduction of the load within 3 minutes); additional aerobic exercises performed sitting and/or standing (30 minutes, 5 days/week); respiratory muscle training (7 days/week, for 15 minutes) using ball trainer.
OTHER: Intervention group
Exercise program as for a control group together with additional resistance and balance training 3 sessions/week. The resistance training was started with low intensity (<30% 1-RM, RPE ≤ 11, 5-10 repetitions), increased gradually to moderate intensity (30-50% and up to 60% 1-RM, RPE 12-13, after 8-15 repetitions) with 3 sets and 3 minute rest between sets, if tolerated. The balance training included exercises to improve static as well as dynamic balance ability. It was performed on 2-3 days/week for 10-15 minutes. The complexity of the balance exercises was selected and incremented individually by changing the stand-position, the base on which the stands were performed and/or using unstable surfaces. If tolerated, the visual information was varied and/or additional tasks performed while balancing. After completion participants were encouraged to continue exercise training at home according to recommendations.
Additional exercise program with balance and resistance training three times per week. After completion participants are encouraged to continue exercise training at home according to recommendations and will receive control calls every two weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical performance by Short Physical Perfromance Battery (SPPB)
Time Frame: Baseline
The short physical performance battery (SPPB) is a group of measures that combines the results of the gait speed, chair stand and balance tests.The scores range from 0 (worst performance) to 12 (best performance).
Baseline
Physical performance by Short Physical Perfromance Battery (SPPB)
Time Frame: 20 days
The short physical performance battery (SPPB) is a group of measures that combines the results of the gait speed, chair stand and balance tests.The scores range from 0 (worst performance) to 12 (best performance).
20 days
Physical performance by Short Physical Perfromance Battery (SPPB)
Time Frame: Three months
The short physical performance battery (SPPB) is a group of measures that combines the results of the gait speed, chair stand and balance tests.The scores range from 0 (worst performance) to 12 (best performance).
Three months
Physical performance by 5 meters walking test (5MWT)
Time Frame: Baseline
5MWT is a gate speed test measured by meters per second.
Baseline
Physical performance by 5 meters walking test (5MWT)
Time Frame: 20 days
5MWT is a gate speed test measured by meters per second.
20 days
Physical performance by 5 meters walking test (5MWT)
Time Frame: 3 months
5MWT is a gate speed test measured by meters per second.
3 months
Functional capacity by six minutes walking test (6MWT)
Time Frame: Baseline
6MWT measured by meters
Baseline
Functional capacity by six minutes walking test (6MWT)
Time Frame: 20 days
6MWT measured by meters
20 days
Functional capacity by six minutes walking test (6MWT)
Time Frame: 3 months
6MWT measured by meters
3 months
Quality of life by questionnaire Short Form Survey SF-36
Time Frame: Baseline
0-100%, the higher score, the better quality of life. The SF-36 measures eight scales: physical functioning (PF), role physical (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role emotional (RE), and mental health (MH) in units on the scale
Baseline
Quality of life by questionnaire Short Form Survey SF-36
Time Frame: 20 days
0-100%, the higher score, the better quality of life. The SF-36 measures eight scales: physical functioning (PF), role physical (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role emotional (RE), and mental health (MH) in units on the scale
20 days
Quality of life by questionnaire Short Form Survey SF-36
Time Frame: 3 months
0-100%, the higher score, the better quality of life. The SF-36 measures eight scales: physical functioning (PF), role physical (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role emotional (RE), and mental health (MH) in units on the scale
3 months
Quality of life by questionnaire Minnesota living with heart failure (Minesota HF)
Time Frame: Baseline
Minesota HF questionnaire in units on the scale, 0-105, the the lower score, the better quality of life
Baseline
Quality of life by questionnaire Minnesota living with heart failure (Minesota HF)
Time Frame: 20 days
Minesota HF questionnaire in units on the scale, 0-105, the the lower score, the better quality of life
20 days
Quality of life by questionnaire Minnesota living with heart failure (Minesota HF)
Time Frame: 3 months
Minesota HF questionnaire in units on the scale, 0-105, the the lower score, the better quality of life
3 months
Quality of life by questionnaire EQ-5D
Time Frame: Baseline
EQ-5D in units on the scale, 0-10, the higher score, the better quality of life
Baseline
Quality of life by questionnaire EQ-5D
Time Frame: 20 days
EQ-5D in units on the scale, 0-10, the higher score, the better quality of life
20 days
Quality of life by questionnaire EQ-5D
Time Frame: 3 months
EQ-5D in units on the scale, 0-10, the higher score, the better quality of life
3 months
Quality of life by questionnaire Quality of Life: Cardiac Index
Time Frame: Baseline
Quality of Life: Cardiac Index in units on the scale, 15-33 the higher score, the better quality of life
Baseline
Quality of life by questionnaire Quality of Life: Cardiac Index
Time Frame: 20 days
Quality of Life: Cardiac Index in units on the scale, 15-33 the higher score, the better quality of life
20 days
Quality of life by questionnaire Quality of Life: Cardiac Index
Time Frame: 3 months
Quality of Life: Cardiac Index in units on the scale, 15-33 the higher score, the better quality of life
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frailty level by SPPB score
Time Frame: baseline
Frailty measured by SPPB score - 0-7 - frail, 8-9 - pre-frail, 10-12 robust.
baseline
Frailty level by SPPB score
Time Frame: 20 days
Frailty measured by SPPB score - 0-7 - frail, 8-9 - pre-frail, 10-12 robust.
20 days
Frailty level by SPPB score
Time Frame: three months
Frailty measured by SPPB score - 0-7 - frail, 8-9 - pre-frail, 10-12 robust.
three months
Frailty level by 5MWT
Time Frame: baseline
Frailty measured by 5MWT - <0,6 m/s - frail, 0,7-0,99 m/s - pre-frail, 1,0 m/s and more - robust
baseline
Frailty level by 5MWT
Time Frame: 20 days
Frailty measured by 5MWT - <0,6 m/s - frail, 0,7-0,99 m/s - pre-frail, 1,0 m/s and more - robust
20 days
Frailty level by 5MWT
Time Frame: three months
Frailty measured by 5MWT - <0,6 m/s - frail, 0,7-0,99 m/s - pre-frail, 1,0 m/s and more - robust
three months
Physical activity by International physical activity questionnaire (IPAQ)
Time Frame: 3 months
IPAQ in units on the scale
3 months
Physical activity by International physical activity questionnaire (IPAQ)
Time Frame: 20 days
IPAQ in units on the scale
20 days
Physical activity by International physical activity questionnaire (IPAQ)
Time Frame: Baseline
IPAQ in units on the scale
Baseline
Cardiopulmonary exercise capacity by maximal oxygen consumption (peakVO2)
Time Frame: Baseline
PeakVO2 measured with spiroergometry by millilitres of oxygen per kilogram of body mass per minute
Baseline
Cardiopulmonary exercise capacity by maximal load (maxWatt)
Time Frame: Baseline
Maximal load measured with spiroergometry by maximal watts
Baseline
Cardiopulmonary exercise capacity by maximal oxygen consumption (peakVO2)
Time Frame: 20 days
PeakVO2 measured with spiroergometry by millilitres of oxygen per kilogram of body mass per minute
20 days
Cardiopulmonary exercise capacity by maximal oxygen consumption (peakVO2)
Time Frame: 3 months
PeakVO2 measured with spiroergometry by millilitres of oxygen per kilogram of body mass per minute
3 months
Cardiopulmonary exercise capacity by maximal load (maxWatt)
Time Frame: 20 days
Maximal load measured with spiroergometry by maximal watts
20 days
Cardiopulmonary exercise capacity by maximal load (maxWatt)
Time Frame: 3 months
Maximal load measured with spiroergometry by maximal watts
3 months
Muscular strength by one repetition maximum test (1RM)
Time Frame: baseline
1RM test for leg extension measured by kilograms
baseline
Muscular strength by one repetition maximum test (1RM)
Time Frame: 20 days
1RM test for leg extension measured by kilograms
20 days
Muscular strength by one repetition maximum test (1RM)
Time Frame: 3 months
1RM test for leg extension measured by kilograms
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Raimondas Kubilius, Prof, Lithuanian University of Health Sciences, Department of Rehabilitation

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

February 26, 2018

Primary Completion (ACTUAL)

February 1, 2020

Study Completion (ACTUAL)

June 30, 2020

Study Registration Dates

First Submitted

January 12, 2020

First Submitted That Met QC Criteria

January 15, 2020

First Posted (ACTUAL)

January 21, 2020

Study Record Updates

Last Update Posted (ACTUAL)

July 16, 2020

Last Update Submitted That Met QC Criteria

July 14, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Life

Clinical Trials on Additional balance and resistance training

3
Subscribe